Guest guest Posted April 23, 2011 Report Share Posted April 23, 2011 BlankChronic Lymphocytic Leukemia With t(14;19)(q32;q13) Is Characterized by Atypical Morphologic and Immunophenotypic Features and Distinctive Genetic Features 1.. Yang O. Huh, MD1, 2.. Carmen D. Schweighofer, MD1, 3.. Rhett P. Ketterling, MD3, 4.. A. Knudson3, 5.. Francisco Vega, MD, PhD1, 6.. Ji E. Kim, MD1, 7.. Rajyalakshmi Luthra, PhD1, 8.. J. Keating, MB, BS2, 9.. L. Medeiros, MD1 and 10.. Lynne V. Abruzzo, MD, PhD1 + Author Affiliations 1.. 1From the Departments of Hematopathology and 2.. 2Leukemia, The University of Texas M. D. Cancer Center, Houston and 3.. 3Division of Laboratory Genetics, Mayo Clinic, Rochester, MN 1.. Address reprint requests to Dr Huh: Dept of Hematopathology, The University of Texas M. D. Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. Abstract The t(14;19)(q32;q13) involving the IGH@ and BCL3 loci is an infrequent cytogenetic abnormality detected in B-cell malignancies. We describe the clinicopathologic, cytogenetic, and molecular genetic characteristics of 14 cases of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with t(14;19)(q32;q13). All patients (10 men and 4 women) had lymphocytosis; 10 had lymphadenopathy. Blood and bone marrow lymphocytes were predominantly small, but cytologically and immunophenotypically atypical. In all cases, t(14;19) was found in the neoplastic stem line; it was the sole abnormality in 4. Ten cases showed additional cytogenetic abnormalities, including trisomy 12 in 9 and complex karyotypes in 7. Fluorescence in situ hybridization demonstrated IGH@/BCL3 fusion gene in all cases. In all cases, the IGHV genes were unmutated, but only 7 expressed ZAP70. Seven cases preferentially used IGHV4-39. Our results indicate that t(14;19)(q32;q13) identifies a subset of CLL/SLL with distinctive clinicopathologic and genetic features. Furthermore, t(14;19) may represent an early, possibly primary, genetic event. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.